Gushengtang Traditional Chinese Medicine
Healthcare services provider based in china
About Gushengtang Traditional Chinese Medicine
Gushengtang Holdings Limited operates as a key player in China's Traditional Chinese Medicine (TCM) sector, positioning itself through an integrated Online-Merge-Offline (OMO) business model. Founded in 2010 by Tu Zhiliang, who serves as Chairman and CEO, the company was established with the vision of blending modern technology with traditional medical practices. Tu's journey into the TCM industry was partly influenced by his family's involvement in the sector, which provided him with insight into the market's potential and the scarcity of high-quality, consistent TCM services.
The company's core business revolves around a network of offline medical institutions and a robust online healthcare platform. Gushengtang provides a comprehensive range of TCM services, including consultations, diagnostics, prescription services, physiotherapy, and the sale of herbal medicines and health products. Its target clients are individuals seeking TCM healthcare solutions, and it operates within the expansive Chinese healthcare market, which has seen significant growth. Revenue is generated primarily through the provision of these healthcare services and the sale of related products across its network. A key strategy has been to attract renowned and experienced TCM practitioners to its platform, addressing the high demand for expert care and making it more accessible to communities.
Gushengtang's service is distinguished by its OMO platform, which integrates online and offline resources to create a seamless patient experience, from appointment scheduling to follow-up care. The company has built a considerable network, with over 70 offline clinics in numerous cities and an online presence serving hundreds of cities across China. A significant milestone was its initial public offering on the Hong Kong Stock Exchange in December 2021, which raised approximately US$104 million to fund further expansion of its online and offline operations and invest in technology and R&D. The company is also venturing into international markets, with its first overseas clinic launched in Singapore, and is developing its own proprietary TCM products, some of which have received international regulatory approval. Furthermore, Gushengtang is leveraging artificial intelligence to create digital avatars of physicians to address resource shortages and to enhance its service model from episodic consultations to continuous health management.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO CONVERTIBLEOther financing | Jan 2026 | $110M | — | Boyu Capital | ↗ |
| IPOOther financing | Dec 2021 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Gushengtang Traditional Chinese Medicine is 98K monthly website visits, up 32.4% over the last three months. Gushengtang Traditional Chinese Medicine's team grew 5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sante Wellness TCMSingapore, SingaporeTraditional Chinese Medicine wellness and massage therapies.
→
LottoFitGuangzhou, ChinaA comprehensive service platform focusing on the digital fitness personal education consumer market
$17Mvaluation
Gushengtang Traditional Chinese Medicine in the Guangzhou ecosystem
The Gushengtang Traditional Chinese Medicine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A1 investor entered at this stage
Boyu Capital
Series B and later6 investors entered at this stage
China Merchants Bank
China Life Insurance
Long Hill Capital
Feihe
NEA- FIFeihe International
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Gushengtang Traditional Chinese Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gushengtang Traditional Chinese Medicine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.












